Sabby Management, LLC Vaxart, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$0.28 - $0.39 $335,358 - $467,106	-1,197,710 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$0.3 - $0.75 $83,118 - $207,797	277,063 Added 30.09%	1,197,710 $430,000
Q2 2019 Aug 14, 2019	BUY	$0.63 - $2.04 $455,896 - $1.48 Million	723,646 Added 367.33%	920,647 $617,000
Q1 2019 May 15, 2019	BUY	$1.5 - $2.34 $295,501 - $460,982	197,001 New	197,001 $382,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.